Neuland Laboratories Limited (NSE:NEULANDLAB)

Neuland Laboratories Revenue

In the fiscal year ending March 31, 2026, Neuland Laboratories had annual revenue of 20.23B INR with 36.98% growth. Neuland Laboratories had revenue of 7.76B in the quarter ending March 31, 2026, with 136.40% growth.

• Revenue: 20.23B
• Revenue Growth: +36.98%
• P/S Ratio: 10.78
• Revenue / Employee: 11.28M
• Employees: 1,794
• Market Cap: 217.99B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	20.23B	5.46B	36.98%
Mar 31, 2025	14.77B	-817.43M	-5.24%
Mar 31, 2024	15.59B	3.67B	30.81%
Mar 31, 2023	11.91B	2.40B	25.20%
Mar 31, 2022	9.52B	147.07M	1.57%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 2, 2026

Data Sources Report a data error